Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. - Wikidata - awgldk - TriplyDB

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.

http://www.wikidata.org/entity/Q38335335

about

Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity Paying attention to smell: cholinergic signaling in the olfactory bulb Dual-transmitter neurons: functional implications of co-release and co-transmission Olfactory Dysfunction in the Elderly: Basic Circuitry and Alterations with Normal Aging and Alzheimer's Disease.Cytoarchitectural changes in the olfactory bulb of Parkinson's disease patients.Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.Development of the main olfactory system and main olfactory epithelium-dependent male mating behavior are altered in Go-deficient mice Olfaction in Parkinson's disease and related disorders.Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease.Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults.Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Olfactory dysfunctions in neurodegenerative disorders.Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.Olfactory system and demyelination.α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.Olfactory bulb involvement in neurodegenerative diseases.Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys.Anosmin-1 over-expression increases adult neurogenesis in the subventricular zone and neuroblast migration to the olfactory bulb.Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Deconstructing the molecular architecture of olfactory areas using proteomics.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.Non-motor features of Parkinson disease.Neurodegenerative changes in the brainstem and olfactory bulb in people older than 50 years old: a descriptive study.Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease.Olfactory impairment in the rotenone model of Parkinson's disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation.Genetic variation modifies risk for neurodegeneration based on biomarker status.Presynaptic gain control by endogenous cotransmission of dopamine and GABA in the olfactory bulb.Immunomorphological Changes in the Olfactory Bulbs of Rats after Intranasal Administration of Rotenone.Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease."Till Death Do Us Part": A Potential Irreversible Link Between Aberrant Cell Cycle Control and Neurodegeneration in the Adult Olfactory Bulb.Brain region-dependent differential expression of alpha-synuclein.On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

P2860

Q26862840-469F109B-BDE7-408C-B666-2C8A64F19B3B Q27008213-2B983A7D-04E8-4DFF-BC19-245C880B8FC1 Q27028038-768F9D14-9E51-490C-B27D-85426D8F9717 Q33898984-F21E921B-6ADD-42AE-A11A-4CEA338C817A Q33917258-135FF371-3E87-4B28-9E9D-2C00F1897591 Q35073958-FAE4655A-D1BD-492D-AF14-9525DF1391F3 Q35208334-D275E75B-EE5C-43B0-9CBE-4C8457739371 Q36131996-0FBDB10C-A510-4666-A642-50EF7D70BF06 Q36193915-83192D03-E3D5-46CB-BB68-3B8A66D00C17 Q36545406-017ADB49-50C0-47E8-B478-FE94360432CC Q36728836-4DE23E8C-0C10-41C4-B851-7D54E85C9CA8 Q37328470-7D2EB78B-913D-4622-BD7A-810D102E7763 Q37487771-3950B67B-ACBE-4FFD-BC80-E6AAB8EA7AC3 Q37733601-DD51D372-A865-4DA5-8065-CD0DC96F685C Q37733707-003DA99A-095A-4945-868E-D40477C5383A Q37955871-02D7CDA0-AE62-4345-BAA2-3F64BF6E11BD Q38016791-64C708DB-A968-4238-9226-4D4BB9EF226E Q38078791-9860C1C4-49A9-421C-90D4-921EBBDCED9B Q38125663-188C7187-77BB-4BCE-A051-F0BED78BB6FE Q38153587-AF1A7B38-6FC9-4021-972E-96B62AE323CF Q38189727-402E9C83-C449-44F2-AF25-1F872379D02D Q38287948-AE8A49DA-A8EB-447D-BFF4-44E49D844FD5 Q38303609-29552A2D-E403-4C22-BF9A-14C3A478DFEB Q38312630-92B2A8D6-1B09-4902-865A-B72EE6132C4D Q38314696-6E6157DD-0A4B-499D-A3A3-3243A9ECC982 Q38598375-313373D3-325B-4FDA-8255-0A1A4AAFC88F Q38844493-CB1BCC7F-41A3-4CF0-BE28-0EA4444255F9 Q39052041-8235462A-C9DA-4560-8FBF-4388A4BB16F8 Q39286812-D14BCA9F-C2FB-48B0-BC4C-97FB2C4F5E8F Q39358549-FEFE07FC-CF52-452C-B4F0-4A0DBFF163EF Q40709414-7CFD7431-C6C0-4C89-8879-09A52DD62E5D Q41668951-A80AB76F-E220-4F39-B50C-E93DE48A6F93 Q41789113-6D00D2C2-8697-4A46-9F3E-06989B94CC31 Q46000358-279DE050-9169-4079-867E-688372DA8B6A Q48110606-13949639-23EC-4AC8-9D01-359BB2040A0F Q49580632-D508AFA0-D3C4-4572-B581-9D4174D8E5D4 Q50566330-DE60CF1E-5E78-4901-8653-58F479C01C08 Q51758706-A850160A-3160-421E-AB6D-726CB944A57E Q52149583-44418D98-529D-4E04-AA22-70167DDB4CDD Q55432445-A0842F09-0ED2-4263-81E3-BD943CAA2331

P2860

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.

http://www.wikidata.org/entity/Q38335335

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Increased dopaminergic cells a ...... h neurodegenerative disorders.

@en

type

label

Increased dopaminergic cells a ...... h neurodegenerative disorders.

@en

prefLabel

Increased dopaminergic cells a ...... h neurodegenerative disorders.

@en

P1433

Q38335335-C6E6B43E-F7FF-4C7C-B5CD-D53FE2E75F5C

P1476

Q38335335-8E4725BE-4DB7-4E9C-BB8F-7E8DDE4F3611

P2093

Q38335335-14254471-28C0-47C4-B00B-4653DFD9C7E3

Q38335335-7E20B8B9-A02C-42A6-8FC7-3F5202FD57F7

Q38335335-8A01C20B-EC57-4661-BE17-01E047062C55

Q38335335-AFCC17AE-0249-4F76-B248-5F05E9A384AC

Q38335335-F07E9915-531D-4182-A91D-014D1764788B

Q38335335-FE9BA81D-2DE1-4975-9563-1BC3A4766929

P2860

Q38335335-0690B7C2-7056-406B-9279-827FF6D88DC5

Q38335335-086D6492-8F7E-43E1-89F5-A1B548141970

Q38335335-093F1CF4-32F0-44CD-AB6A-AF0C01C2F5B2

Q38335335-14706833-066B-41B1-9F99-F4C78069E600

Q38335335-15259FBB-EF12-4CED-95C8-74B4373FBAFA

Q38335335-1984D01A-F74B-4970-9E5B-6D30478BA6DC

Q38335335-1C166C6D-8C10-49F8-B386-88A640425AC1

Q38335335-1D01181E-2789-4F8B-A823-2AB063DCEE61

Q38335335-1DB7D07D-25A4-477B-B7A9-A812A29A0A54

Q38335335-206512E3-2C7C-41A2-BE60-A2F8050316B8

P2888

Q38335335-D376E71D-7D11-4FF2-97C5-F22197E63710

P304

Q38335335-37D4274E-5D05-40FE-8266-19287D6FEBEC

P31

Q38335335-C529A579-DB33-496E-AEB4-DD15BC0AD1C0

P356

Q38335335-9191459F-55A5-49F2-8A1F-AC178249B430

P433

Q38335335-F975D8A3-51D8-40C2-9A2D-1521946CA58A

P478

Q38335335-679BC0A1-60B8-4CCD-83EA-698CE57FA375

P50

Q38335335-24EC0910-37B8-43DD-BC0B-93FAABC003EF

Q38335335-BA44B13A-E8CA-4AA1-9BB9-643326D4B75E

Q38335335-C8E1084C-08B8-4F00-B321-63AE27A3648A

P577

Q38335335-08872A74-B07A-4F2D-820D-8DF01389E128

P5875

Q38335335-1DF1206E-53BE-4A46-9491-385FA9A77C4C

P6179

Q38335335-D304FBCA-4396-4F83-9400-C0C1A419335B

P698

Q38335335-53B442FA-010D-4EF6-ADE9-4C88AC398638

P921

Q38335335-17BBC7A8-ABD2-4A26-97FF-BAC8E39AEB79

Q38335335-677073D2-5E25-47AF-9430-2530EF8275A6

P356

S00401-011-0830-2

P1433

Acta Neuropathologica

P1476

Increased dopaminergic cells a ...... th neurodegenerative disorders

@en

P2093

Carla DiCaudo

http://www.w3.org/2001/XMLSchema#string

Cristina Ordóñez

http://www.w3.org/2001/XMLSchema#string

Maria Hernandez

http://www.w3.org/2001/XMLSchema#string

Maria-Cristina Caballero

http://www.w3.org/2001/XMLSchema#string

Maria-Elena Erro

http://www.w3.org/2001/XMLSchema#string

Maria-Teresa Tuñon

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Staging of brain pathology related to sporadic Parkinson's disease

Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation

Serotonergic modulation of odor input to the mammalian olfactory bulb

Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

P2888

s00401-011-0830-2

P304

61-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-011-0830-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Maria-Rosario Luquin

Inaki-Carril Mundinano

P577

2011-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51108576

http://www.w3.org/2001/XMLSchema#string

P6179

1045348226

http://www.w3.org/2001/XMLSchema#string

P698

21553300

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration